RecruitingNot ApplicableNCT07125833

Cryoneurolysis of the Suprascapular Nerve for Perioperative Pain Control After Receiving a Reverse Total Shoulder Arthroplasty (RTSA)

A Randomized Pilot Trial for Cryoneurolysis of the Suprascapular Nerve for Perioperative Pain Control After Receiving a Reverse Total Shoulder Arthroplasty

Sponsor

North Texas Medical Research Institute, PLLC

Enrollment

20 participants

Start Date

Jul 30, 2025

Study Type

INTERVENTIONAL

Conditions

Degenerative Joint Disease of Shoulder

Summary

The main purpose of this research is to find out if a treatment called cryoneurolysis can reduce pain after reverse total shoulder replacement surgery. This treatment uses cold to temporarily block a nerve in the shoulder. The study will compare people who receive the treatment to those who do not, to see if it helps lower pain and reduce the need for opioid pain medications after a reverse total shoulder surgery (RTSA).

Eligibility

Min Age: 30 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Cryoneurolysis and No cryoneurolysis for people with degenerative joint disease of shoulder. The study is currently recruiting participants at 1 location. People eligible for this study include aged 30 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECryoneurolysis

Cryoneurolysis of the suprascapular nerve

OTHERNo cryoneurolysis

Control Group

Locations(1)

Orthopaedic Specialists of Dallas

Rockwall, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07125833